220 SOUTH ORANGE AVENUE, LIVINGSTON, NJ
Strengthens Board to Support Next Phase of Growth
Stock Option Exchange Program Approved for CEO Eric Hines and SVP Jason Papes
Milestone Scientific Inc. Dismisses CBIZ CPAs, Engages Grassi & Co.
Completes $2.15 Million Private Placement Financing
Amendment to MOU with Innovest S.p.A. Facilitates Qualified Offering
Milestone Scientific Inc. Increases Authorized Shares to 125 Million
Amended material disclosure
Material Agreement with Innovest S.p.A. Regarding BP4 Lock-Up
Q1
Amended Annual Report
Q3
Q2
FY 2024
Notice of Late Filing for Annual Report
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRER14A
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Prospectus Filed Pursuant to Rule 424(b)(1)
Correspondence
Submission Upload